News
MRMD
0.069
+1.47%
0.001
MariMed shareholders approve M&K CPAs as 2026 auditor at annual meeting
PUBT · 5d ago
Weekly Report: what happened at MRMD last week (0601-0605)?
Weekly Report · 6d ago
Weekly Report: what happened at MRMD last week (0525-0529)?
Weekly Report · 06/01 10:02
Marimed CEO Jon Levine acquires $4,500 of common shares
PUBT · 05/26 20:31
Weekly Report: what happened at MRMD last week (0518-0522)?
Weekly Report · 05/25 10:04
Marimed CEO Jon Levine buys 40,000 shares for $3,000
PUBT · 05/20 20:08
Weekly Report: what happened at MRMD last week (0511-0515)?
Weekly Report · 05/18 10:04
Analysts Are Bullish on These Healthcare Stocks: Milestone Scientific (MLSS), Inhibikase Therapeutics (IKT)
TipRanks · 05/15 13:30
MariMed Balances Growth, Margin Gains Amid Market Pressures
TipRanks · 05/15 00:25
MariMed forecasts licensing revenue early next year while planning Ohio store opening before year-end
Seeking Alpha · 05/14 14:10
Press Release: MariMed Reports First Quarter 2026 Earnings
Dow Jones · 05/13 21:46
MariMed Q1 Adj. EPS $(0.01), Inline, Sales $39.481M Beat $38.750M Estimate
Benzinga · 05/13 21:37
Cannabis operator MariMed Q1 revenue rises, adjusted EBITDA improves
Reuters · 05/13 21:08
MariMed GAAP EPS of -$0.01 in-line, revenue of $39.48M beats by $0.73M
Seeking Alpha · 05/13 21:07
BRIEF-MariMed Q1 Adjusted EBITDA USD 3.6 Million
Reuters · 05/13 21:00
MARIMED REPORTS FIRST QUARTER 2026 EARNINGS
Reuters · 05/13 21:00
Here are the major earnings after the close Wednesday
Seeking Alpha · 05/13 14:00
Weekly Report: what happened at MRMD last week (0504-0508)?
Weekly Report · 05/11 10:02
Weekly Report: what happened at MRMD last week (0427-0501)?
Weekly Report · 05/04 10:01
Weekly Report: what happened at MRMD last week (0420-0424)?
Weekly Report · 04/27 10:03
More
Webull provides a variety of real-time MRMD stock news. You can receive the latest news about Marimed through multiple platforms. This information may help you make smarter investment decisions.
About MRMD
MariMed Inc. is a multi-state cannabis operator in the United States. The Company develops, owns, and manages seed to sale of state-licensed cannabis facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. It develops its own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products utilizing its proprietary strains and formulations. It also licenses its proprietary brands, along with other cannabis products, in domestic markets. Its products are developed in various consumption formats, including whole flower, pre-rolled flower, vape cartridges, concentrates, and edibles. The Company’s brands include Nature’s Heritage, a premium brand of cannabis flower, vapes, and concentrates; Betty’s Eddies, cannabis fruit chews that deliver better sleep, pain relief, stress relief, and more. The Betty's Eddies line also includes a cannabis-infused ice cream created in partnership with ice cream brand Emack & Bolio's.